Neuroinflammation and the generation of neuropathic pain

被引:447
|
作者
Ellis, A. [1 ]
Bennett, D. L. H. [2 ]
机构
[1] Kings Coll London, London SE1 1UL, England
[2] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England
基金
英国惠康基金;
关键词
immune response; pain; neuropathic; DORSAL-ROOT GANGLION; PERIPHERAL-NERVE INJURY; MONOCYTE CHEMOATTRACTANT PROTEIN-1; PRO-INFLAMMATORY CYTOKINES; SPINAL-CORD MICROGLIA; NECROSIS-FACTOR-ALPHA; CATHEPSIN-S; RAT MODEL; IMMUNE-SYSTEM; UP-REGULATION;
D O I
10.1093/bja/aet128
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Inflammation is the process by which an organism responds to tissue injury involving both immune cell recruitment and mediator release. Diverse causes of neuropathic pain are associated with excessive inflammation in both the peripheral and central nervous system which may contribute to the initiation and maintenance of persistent pain. Chemical mediators, such as cytokines, chemokines, and lipid mediators, released during an inflammatory response have the undesired effect of sensitizing and stimulating nociceptors, their central synaptic targets or both. These changes can promote long-term maladaptive plasticity resulting in persistent neuropathic pain. This review aims to provide an overview of inflammatory mechanisms at differing levels of the sensory neuroaxis with a focus on neuropathic pain. We will compare and contrast neuropathic pain states such as traumatic nerve injury which is associated with a vigorous inflammatory response and chemotherapy induced pain in which the inflammatory response is much more modest. Targeting excessive inflammation in neuropathic pain provides potential therapeutic opportunities and we will discuss some of the opportunities but also the clinical challenges in such an approach.
引用
收藏
页码:26 / 37
页数:12
相关论文
共 50 条
  • [41] An integrated review on new targets in the treatment of neuropathic pain
    Khangura, Ravneet Kaur
    Sharma, Jasmine
    Bali, Anjana
    Singh, Nirmal
    Jaggi, Amteshwar Singh
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2019, 23 (01) : 1 - 20
  • [42] NOX4 is an early initiator of neuropathic pain
    Geis, Christian
    Geuss, Eva
    Sommer, Claudia
    Schmidt, Harald H. H. W.
    Kleinschnitz, Christoph
    EXPERIMENTAL NEUROLOGY, 2017, 288 : 94 - 103
  • [43] Blood-nerve barrier dysfunction contributes to the generation of neuropathic pain and allows targeting of injured nerves for pain relief
    Lim, Tony K. Y.
    Shi, Xiang Qun
    Martin, Hiliary Claire
    Huang, Hao
    Luheshi, Giamal
    Rivest, Serge
    Zhang, Ji
    PAIN, 2014, 155 (05) : 954 - 967
  • [44] Neuropathic pain in cancer survivors
    Garg, Rakesh
    Bhatnagar, Sushma
    PAIN MANAGEMENT, 2014, 4 (04) : 309 - 316
  • [45] Microglia: sculptors of neuropathic pain?
    Ward, Harry
    West, Steven J.
    ROYAL SOCIETY OPEN SCIENCE, 2020, 7 (06):
  • [46] Ammoxetine attenuates diabetic neuropathic pain through inhibiting microglial activation and neuroinflammation in the spinal cord
    Zhang, Ting-Ting
    Xue, Rui
    Fan, Shi-Yong
    Fan, Qiong-Yin
    An, Lei
    Li, Juan
    Zhu, Lei
    Ran, Yu-Hua
    Zhang, Li-Ming
    Zhong, Bo-Hua
    Li, Yun-Feng
    Ye, Cai-Ying
    Zhang, You-Zhi
    JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [47] Focus on topiramate in neuropathic pain
    Dib, JG
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (12) : 1857 - 1861
  • [48] Epigenetic Modification in Neuropathic Pain
    Ueda, Hiroshi
    Uchida, Hitoshi
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (07) : 849 - 867
  • [49] Introduction to Neuropathic Pain Syndromes
    Gutierrez, Juanmarco
    Raju, Sukreet
    Riley, Jonathan P.
    Boulis, Nicholas M.
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2014, 25 (04) : 639 - +
  • [50] Understanding and Treating Neuropathic Pain
    Stemkowski, P. L.
    Biggs, J. E.
    Chen, Y.
    Bukhanova, N.
    Kumar, N.
    Smith, P. A.
    NEUROPHYSIOLOGY, 2013, 45 (01) : 67 - 78